Serum ready for Covishield rollout as soon as it receives DCGI nod

Serum ready for Covishield rollout as soon as it receives DCGI nod

World's biggest vaccine maker has already manufactured over 50 million doses; further production will start as soon as it gets necessary approvals in India and the UK. SII is hoping to supply 3 billion doses of vaccine in 2021

Advertisement
India plans to start the world's biggest mass inoculation drive in JanuaryIndia plans to start the world's biggest mass inoculation drive in January
BusinessToday.In
  • Dec 24, 2020,
  • Updated Dec 24, 2020 1:41 PM IST

Serum Institute of India, which is manufacturing one of the top three vaccine candidates in India, is ready for the vaccine rollout as soon as it receives a green signal from the drug regulatory authority. The world's biggest vaccine maker has already manufactured over 50 million doses of the vaccine, which is developed by Oxford University and Swedish-British pharma major AstraZeneca.

Advertisement

Further production will start as soon as it gets necessary approvals in India and the UK. They are hoping to supply 3 billion doses of the vaccine in 2021.

The vaccine maker is also working with the government to prepare a distribution plan. "Everything is ready for rollout; we are only waiting for regulator's review... which city will get the vaccine first depends on the government," The Economic Times quoted an official as saying.

Serum Institute of India, which is manufacturing one of the top three vaccine candidates in India, is ready for the vaccine rollout as soon as it receives a green signal from the drug regulatory authority. The world's biggest vaccine maker has already manufactured over 50 million doses of the vaccine, which is developed by Oxford University and Swedish-British pharma major AstraZeneca.

Advertisement

Further production will start as soon as it gets necessary approvals in India and the UK. They are hoping to supply 3 billion doses of the vaccine in 2021.

The vaccine maker is also working with the government to prepare a distribution plan. "Everything is ready for rollout; we are only waiting for regulator's review... which city will get the vaccine first depends on the government," The Economic Times quoted an official as saying.

Read more!
Advertisement